Intelligent Bio Solutions Inc. reported revenue from sales of goods of $1.1 million for the three months ended September 30, 2025, an increase of $0.2 million from $0.9 million in the same period in 2024, mainly due to expansion of the customer base. The company recorded a net loss attributable to Intelligent Bio Solutions Inc. of $3.0 million for the quarter, compared to a net loss of $2.7 million in the prior-year period. Total operating expenses rose to $3.7 million from $3.2 million year-over-year. The company reported a comprehensive loss of $2.9 million, up from $2.5 million in the previous year. Expansion into new markets is expected to continue.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-021751), on November 12, 2025, and is solely responsible for the information contained therein.
Comments